Skip to main content

Table 1 General characteristics of study population

From: Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients

Characteristics CIPN Cases (148) Controls (835)
Mean age 57.48 57.30
Gender male % 86 (58%) 493 (59%)
History of neuropathy 21 (14.2%) 30 (3.6%)
  Medication Medication
Bortezomib Vincristine Thalidomide Bortezomib Vincristine Thalidomide
Study HD3 4 6 53 40
HD4 28 15 116 132
MM5 47 394
NTP 27 10 11 34 60 6
Total 102 (68.9%) 29 (19.6%) 17 (11.5%) 544 (65.2%) 245 (29.3%) 46 (5.5%)
  1. CIPN chemotherapy-induced peripheral neuropathy, NTP non-trial patients